383 related articles for article (PubMed ID: 17132572)
1. The global economic burden of alcohol: a review and some suggestions.
Baumberg B
Drug Alcohol Rev; 2006 Nov; 25(6):537-51. PubMed ID: 17132572
[TBL] [Abstract][Full Text] [Related]
2. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.
Chisholm D; Doran C; Shibuya K; Rehm J
Drug Alcohol Rev; 2006 Nov; 25(6):553-65. PubMed ID: 17132573
[TBL] [Abstract][Full Text] [Related]
3. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.
Jané-Llopis E; Matytsina I
Drug Alcohol Rev; 2006 Nov; 25(6):515-36. PubMed ID: 17132571
[TBL] [Abstract][Full Text] [Related]
4. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
5. Global burden of disease from alcohol, illicit drugs and tobacco.
Rehm J; Taylor B; Room R
Drug Alcohol Rev; 2006 Nov; 25(6):503-13. PubMed ID: 17132570
[TBL] [Abstract][Full Text] [Related]
6. Reducing the burden of smoking world-wide: effectiveness of interventions and their coverage.
Jha P; Chaloupka FJ; Corrao M; Jacob B
Drug Alcohol Rev; 2006 Nov; 25(6):597-609. PubMed ID: 17132576
[TBL] [Abstract][Full Text] [Related]
7. The worldwide societal costs of dementia: Estimates for 2009.
Wimo A; Winblad B; Jönsson L
Alzheimers Dement; 2010 Mar; 6(2):98-103. PubMed ID: 20298969
[TBL] [Abstract][Full Text] [Related]
8. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies.
Ranson MK; Jha P; Chaloupka FJ; Nguyen SN
Nicotine Tob Res; 2002 Aug; 4(3):311-9. PubMed ID: 12215240
[TBL] [Abstract][Full Text] [Related]
9. Global economic and health benefits of tobacco control: part 2.
Wipfli H; Samet JM
Clin Pharmacol Ther; 2009 Sep; 86(3):272-80. PubMed ID: 19536066
[TBL] [Abstract][Full Text] [Related]
10. Global economic and health benefits of tobacco control: part 1.
Wipfli H; Samet JM
Clin Pharmacol Ther; 2009 Sep; 86(3):263-71. PubMed ID: 19536067
[TBL] [Abstract][Full Text] [Related]
11. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
[TBL] [Abstract][Full Text] [Related]
12. Mental health system financing in developing countries: policy questions and research responses.
Chisholm D
Epidemiol Psichiatr Soc; 2007; 16(4):282-8. PubMed ID: 18333422
[TBL] [Abstract][Full Text] [Related]
13. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
14. The cost of alcohol in California.
Rosen SM; Miller TR; Simon M
Alcohol Clin Exp Res; 2008 Nov; 32(11):1925-36. PubMed ID: 18717655
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease.
Oldridge NB
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):130-9. PubMed ID: 18391637
[TBL] [Abstract][Full Text] [Related]
16. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
Ritter A; Cameron J
Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
18. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
19. WHO Expert Committee on Problems Related to Alcohol Consumption. Second report.
WHO Expert Committee on Problems Related to Alcohol Consumption
World Health Organ Tech Rep Ser; 2007; (944):1-53, 55-7, back cover. PubMed ID: 17970166
[TBL] [Abstract][Full Text] [Related]
20. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
